Loblaw Companies Limited · TSX:L
Loblaw Companies — Q1 2017 Earnings Presentation
6 slides from Loblaw Companies's earnings presentation, May 3, 2017
Slide 1: Q1 2017 Supplementary Slides
Q1 2017 Supplementary Slides May 3, 2017 1
Slide 2: Forward-looking Statements
Forward-looking Statements This presentation for Loblaw Companies Limited (“Loblaw” or “the Company”) contains forward-looking statements about the Company’s objectives, plans, goals, aspirations, strategies, financial condition, results of operations, cash flows, performance, prospects, opport unit
Slide 3: Key Financial Metrics – Q1 2017
Key Financial Metrics – Q1 2017 Consolidated Revenue $ 10,401M +0.2% Adjusted EBITDAand Margin $ 865M +4.3% +8.3% +30bps Adjusted Diluted Earnings Per Common +9.8% $ 0.90 Share Free Cash Flow $ 77M QTD (2016 $512M) Capex ($) $ 154M QTD (2016 $157M) 3
Slide 4: Key Retail Metrics – Q1 2017
Key Retail Metrics – Q1 2017 Total Retail Revenue $ 10,166M +0.1% Retail Revenue - Food Retail $ 7,393M flat Retail Revenue - Drug Retail $ 2,773M +0.3% $ 2,705M 27.0% +10bps Retail Adjusted Gross Profit & Margin- Excluding the impact of the consolidation of franchises (As Reported: $2,844 million;
Slide 5: Key Operational Metrics – Q1 2017 – Food Retail (Loblaw)
Key Operational Metrics–Q1 2017—Food Retail (Loblaw) Food Retail SSS Growth ex gas bar Relatively flat Excluding the estimated impacts of the timing of New Year’s Day (Including the impact of New Year’s Day and Easter, SSS growth was and Easter -2.1%) Basket Size Traffic Internal inflation was relat
Slide 6: Key Operational Metrics – Q1 2017 – Drug Retail (Shoppers Drug Mart)
Key Operational Metrics – Q1 2017 Drug Retail (Shoppers Drug Mart) Pharmacy Sales $ 1,343M +2.3% Pharmacy SSS +1.4% Excluding the estimated impacts of the timing of New Year’s Day (Including the unfavourable impacts of the timing of New Year’s Day and and Easter Easter Pharmacy SSS was 1.3%.) # Rx D